{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:01:00Z","timestamp":1793865660594,"version":"4.6.1"},"reference-count":68,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Background and purpose: Many prostate cancer patients undergoing pelvic lymph node dissection (PLND) have no sign of lymph node invasion (LNI) during final pathological assessment. To improve preoperative staging accuracy, we developed the Oslo model, which estimates the risk of LNI based on clinical, histopathological, and magnetic resonance imaging (MRI) variables.\nPatients\/materials and methods: We utilized data from 903 prostate cancer patients treated at Oslo University Hospital (OUS) to develop the model using Bayesian logistic regression. The Oslo model was validated with data from 189 patients at IRCCS Ospedale San Raffaele (HRS), 157 from St. Olav\u2019s Hospital, and 231 from OUS. We assessed its performance against the Memorial Sloan Kettering Cancer Centre (MSKCC) and Briganti 2019 nomograms using metrics like AUC, R\u00b2, decision curve analysis, and calibration plots.\nResults: The Oslo model outperformed Briganti 2019, demonstrating a higher net benefit and a 10% reduction in interventions at a 7% cutoff. Key variables included clinical T stage on MRI, Prostate Specific Antigen (PSA), prostate volume, International Society of Urological Pathology grade group, and maximum lesion length on MRI. Validation showed strong reliability in the OUS and HRS cohorts but weaker performance in the St. Olav\u2019s cohort. The AUCs were 77% for the Oslo model, 74% for Briganti 2019, and 66% for MSKCC. Limitations include small and heterogeneous validation cohorts.\nInterpretation: The Oslo model enhances predictive performance in intermediate- and high-risk patients using easily accessible clinical and MRI data, potentially reducing unnecessary PLND interventions and assisting clinicians in treatment decision-making.<\/jats:p>","DOI":"10.2340\/1651-226x.2025.43970","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:34:42Z","timestamp":1761132882000},"page":"1446-1454","source":"Crossref","is-referenced-by-count":1,"title":["Development and evaluation of a lymph node invasion risk prediction model in intermediate- and high-risk prostate cancer patients"],"prefix":"10.2340","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5434-6029","authenticated-orcid":false,"given":"H\u00e5kon","family":"Ramberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1317-7422","authenticated-orcid":false,"given":"Manuela","family":"Zucknick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Barletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Davik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5smund","family":"Nyb\u00f8en","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Magne","family":"Eri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivanthe","family":"Sivanesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut H\u00e5kon","family":"Hole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tord","family":"Hompland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stian Ole","family":"Prestbakk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tone Frost","family":"Bathen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5530-4915","authenticated-orcid":false,"given":"Kristin","family":"Austild Tasken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"130392","doi-asserted-by":"crossref","unstructured":"Wang H, Xia Z, Xu Y, Sun J, Wu J. The predictive value of machine learning and nomograms for lymph node metastasis of prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2023;26(3):602\u201313.","DOI":"10.1038\/s41391-023-00704-z"},{"key":"130393","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41391-023-00704-z","DOI":"10.1038\/s41391-023-00704-z"},{"key":"130394","doi-asserted-by":"crossref","unstructured":"Dong B, Zhan H, Luan T, Wang J. The role and controversy of pelvic lymph node dissection in prostate cancer treatment: a focused review. World J Surg Oncol. 2024;22(1):68.","DOI":"10.1186\/s12957-024-03344-2"},{"key":"130395","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s12957-024-03344-2","DOI":"10.1186\/s12957-024-03344-2"},{"key":"130396","doi-asserted-by":"crossref","unstructured":"Hope TA, Eiber M, Armstrong WR, Juarez R, Murthy V, Lawhn-Heath C, et al. Diagnostic accuracy of 68 Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 imaging trial. JAMA Oncol. 2021;7(11):1635.","DOI":"10.1001\/jamaoncol.2021.3771"},{"key":"130397","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamaoncol.2021.3771","DOI":"10.1001\/jamaoncol.2021.3771"},{"key":"130398","doi-asserted-by":"crossref","unstructured":"Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N, et al. A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies. Eur Urol. 2019;75(3):506\u201314.","DOI":"10.1016\/j.eururo.2018.10.012"},{"key":"130399","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.eururo.2018.10.012","DOI":"10.1016\/j.eururo.2018.10.012"},{"key":"130400","doi-asserted-by":"crossref","unstructured":"Draulans C, Everaerts W, Isebaert S, Van Bruwaene S, Gevaert T, Oyen R, et al. Development and external validation of a multiparametric magnetic resonance imaging and International Society of Urological Pathology based add-on prediction tool to identify prostate cancer candidates for pelvic lymph node dissection. J Urol. 2020;203(4):713\u201318.","DOI":"10.1097\/JU.0000000000000652"},{"key":"130401","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/JU.0000000000000652","DOI":"10.1097\/JU.0000000000000652"},{"key":"130402","unstructured":"Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Calster BV, et al. TRI-POD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378."},{"key":"130403","unstructured":"Norwegian Institute of Public Health, Cancer Registry of Norway, Norwegian Prostate Cancer Registry. Annual reports [Internet]. 2021. [last visited April 2025] Available from: https:\/\/www.fhi.no\/kreft\/kvalitetsregistrene\/prostatakreft\/Resultater\/"},{"key":"130404","doi-asserted-by":"crossref","unstructured":"Hompland T, Hole KH, Ragnum HB, Aarnes EK, Vlatkovic L, Lie AK, et al. Combined MR imaging of oxygen consumption and supply reveals tumor hypoxia and aggressiveness in prostate cancer patients. Cancer Res. 2018;78(16):4774\u201385.","DOI":"10.1158\/0008-5472.CAN-17-3806"},{"key":"130405","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3806","DOI":"10.1158\/0008-5472.CAN-17-3806"},{"key":"130406","doi-asserted-by":"crossref","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, et al. PI-RADS prostate imaging \u2013 reporting and data system: 2015, version 2. Eur Urol. 2016;69(1):16\u201340.","DOI":"10.1016\/j.eururo.2015.08.052"},{"key":"130407","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.eururo.2015.08.052","DOI":"10.1016\/j.eururo.2015.08.052"},{"key":"130408","doi-asserted-by":"crossref","unstructured":"Egevad L, Delahunt B, Srigley JR, Samaratunga H. International Society of Urological Pathology (ISUP) grading of prostate cancer \u2013 an ISUP consensus on contemporary grading. APMIS. 2016;124(6):433\u20135.","DOI":"10.1111\/apm.12533"},{"key":"130409","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/apm.12533","DOI":"10.1111\/apm.12533"},{"key":"130410","doi-asserted-by":"crossref","unstructured":"Prendeville S, Berney DM, Bubendorf L, Comp\u00e9rat E, Egevad L, Hes O, et al. Handling and reporting of pelvic lymphadenectomy specimens in prostate and bladder cancer: a web-based survey by the European Network of Uropathology. Histopathology. 2019;74(6):844\u201352.","DOI":"10.1111\/his.13818"},{"key":"130411","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/his.13818","DOI":"10.1111\/his.13818"},{"key":"130412","doi-asserted-by":"crossref","unstructured":"Riley RD, Snell KIE, Ensor J, Burke DL, Harrell FE, Moons KGM, et al. Minimum sample size for developing a multivariable prediction model: part I \u2013 continuous outcomes. Stat Med. 2019;38(7):1262\u201375.","DOI":"10.1002\/sim.7993"},{"key":"130413","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/sim.7993","DOI":"10.1002\/sim.7993"},{"key":"130414","unstructured":"Ensor J, Martin EC, Riley RD. pmsampsize: sample size for development of a prediction model [Internet]. 2022. [Last visited October 2023] Available from: https:\/\/CRAN.R-project.org\/package=pmsampsize"},{"key":"130415","unstructured":"Harrell F. rmsb: Bayesian regression modeling strategies [Internet]. 2023. [Last visited October 2023] Available from: https:\/\/CRAN.R-project.org\/package=rmsb"},{"key":"130416","doi-asserted-by":"crossref","unstructured":"Piironen J, Vehtari A. Comparison of Bayesian predictive methods for model selection. Stat Comput. 2017;27(3):711\u201335.","DOI":"10.1007\/s11222-016-9649-y"},{"key":"130417","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s11222-016-9649-y","DOI":"10.1007\/s11222-016-9649-y"},{"key":"130418","doi-asserted-by":"crossref","unstructured":"Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, et al. Clinically localized prostate cancer: AUA\/ASTRO guideline, part II: principles of active surveillance, principles of surgery, and follow-up. J Urol. 2022;208(1):19\u201325.","DOI":"10.1097\/JU.0000000000002758"},{"key":"130419","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/JU.0000000000002758","DOI":"10.1097\/JU.0000000000002758"},{"key":"130420","doi-asserted-by":"crossref","unstructured":"Cornford P, Van Den Bergh RCN, Briers E, Van Den Broeck T, Brunck-horst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guide-lines on prostate cancer \u2013 2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024;86(2):148\u201363.","DOI":"10.1016\/j.eururo.2024.03.027"},{"key":"130421","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027","DOI":"10.1016\/j.eururo.2024.03.027"},{"key":"130422","unstructured":"MSKCC. Prostate cancer nomograms: dynamic prostate cancer nomogram: coefficients [Internet]. Memorial Sloan Kettering Cancer Center. [Last visited March 2024] Available from: https:\/\/www.mskcc.org\/nomograms\/prostate\/pre_op\/coefficients"},{"key":"130423","doi-asserted-by":"crossref","unstructured":"Briganti A, Larcher A, Abdollah F, Capitanio U, Gallina A, Suardi N, et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol. 2012;61(3):480\u20137.","DOI":"10.1016\/j.eururo.2011.10.044"},{"key":"130424","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.eururo.2011.10.044","DOI":"10.1016\/j.eururo.2011.10.044"},{"key":"130425","doi-asserted-by":"crossref","unstructured":"Diamand R, Oderda M, Albisinni S, Fourcade A, Fournier G, Benamran D, et al. External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: a European multicenter study. Urol Oncol. 2020;38(11):847.e9\u201316.","DOI":"10.1016\/j.urolonc.2020.04.011"},{"key":"130426","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.04.011","DOI":"10.1016\/j.urolonc.2020.04.011"},{"key":"130427","doi-asserted-by":"crossref","unstructured":"Vergouwe Y, Nieboer D, Oostenbrink R, Debray TPA, Murray GD, Kattan MW, et al. A closed testing procedure to select an appropriate method for updating prediction models. Stat Med. 2017;36(28):4529\u201339.","DOI":"10.1002\/sim.7179"},{"key":"130428","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/sim.7179","DOI":"10.1002\/sim.7179"},{"key":"130429","unstructured":"Dahly D. [Last visited October 2023] Available from: https:\/\/darrendahly.github.io\/post\/homr"},{"key":"130430","doi-asserted-by":"crossref","unstructured":"Curtin D, Dahly DL, van Smeden M, O\u2019Donnell DP, Doyle D, Gallagher P, et al. Predicting 1-year mortality in older hospitalized patients: external validation of the HOMR model. J Am Geriatr Soc. 2019;67(7):1478\u201383.","DOI":"10.1111\/jgs.15958"},{"key":"130431","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jgs.15958","DOI":"10.1111\/jgs.15958"},{"key":"130432","unstructured":"R Core Team RCT. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2022."},{"key":"130433","unstructured":"Allaire JJ. RStudio: integrated development environment for R. Boston, MA: Posit Software, PBC; 2022."},{"key":"130434","doi-asserted-by":"crossref","unstructured":"Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128\u201338.","DOI":"10.1097\/EDE.0b013e3181c30fb2"},{"key":"130435","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/EDE.0b013e3181c30fb2","DOI":"10.1097\/EDE.0b013e3181c30fb2"},{"key":"130436","doi-asserted-by":"crossref","unstructured":"Heidenreich A, Ohlmann CH, Polyakov S. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. Eur Urol. 2007;52(1):29\u201337.","DOI":"10.1016\/j.eururo.2007.04.020"},{"key":"130437","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.eururo.2007.04.020","DOI":"10.1016\/j.eururo.2007.04.020"},{"key":"130438","doi-asserted-by":"crossref","unstructured":"Wibmer AG, Nikolovski I, Chaim J, Lakhman Y, Lefkowitz RA, Sala E, et al. Local extent of prostate cancer at MRI versus prostatectomy histopathology: associations with long-term oncologic outcomes. Radiology. 2022;302(3):595\u2013602.","DOI":"10.1148\/radiol.210875"},{"key":"130439","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1148\/radiol.210875","DOI":"10.1148\/radiol.210875"},{"key":"130440","doi-asserted-by":"crossref","unstructured":"Meijer D, Van Leeuwen PJ, Roberts MJ, Siriwardana AR, Morton A, Yaxley JW, et al. External validation and addition of prostate-specific membrane antigen positron emission tomography to the most frequently used nomograms for the prediction of pelvic lymph-node metastases: an International Multicenter Study. Eur Urol. 2021;80(2):234\u201342.","DOI":"10.1016\/j.eururo.2021.05.006"},{"key":"130441","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.eururo.2021.05.006","DOI":"10.1016\/j.eururo.2021.05.006"},{"key":"130442","doi-asserted-by":"crossref","unstructured":"Jenkins DA, Martin GP, Sperrin M, Riley RD, Debray TPA, Collins GS, et al. Continual updating and monitoring of clinical prediction models: time for dynamic prediction systems? Diagn Progn Res. 2021;5(1):1.","DOI":"10.1186\/s41512-020-00090-3"},{"key":"130443","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s41512-020-00090-3","DOI":"10.1186\/s41512-020-00090-3"},{"key":"130444","doi-asserted-by":"crossref","unstructured":"Oderda M, Diamand R, Albisinni S, Calleris G, Carbone A, Falcone M, et al. Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion. BJU Int. 2021;127(3):318\u201325.","DOI":"10.1111\/bju.15220"},{"key":"130445","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bju.15220","DOI":"10.1111\/bju.15220"},{"key":"130446","doi-asserted-by":"crossref","unstructured":"Feuer Z, Meng X, Rosenkrantz AB, Kasivisvanathan V, Moore CM, Huang R, et al. Application of the PRECISION trial biopsy strategy to a contemporary magnetic resonance imaging-targeted biopsy cohort-how many clinically significant prostate cancers are missed? J Urol. 2021;205(3):740\u20137.","DOI":"10.1097\/JU.0000000000001406"},{"key":"130447","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/JU.0000000000001406","DOI":"10.1097\/JU.0000000000001406"},{"key":"130448","doi-asserted-by":"crossref","unstructured":"Vis AN, Meijer D, Roberts MJ, Siriwardana AR, Morton A, Yaxley JW, et al. Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography. Eur Urol Oncol. 2023;6(6):553\u201363.","DOI":"10.1016\/j.euo.2023.03.010"},{"key":"130449","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.euo.2023.03.010","DOI":"10.1016\/j.euo.2023.03.010"},{"key":"130450","doi-asserted-by":"crossref","unstructured":"Gandaglia G, Barletta F, Robesti D, Scuderi S, Rajwa P, Gomez Rivas J, et al. Identification of the optimal candidates for nodal staging with extended pelvic lymph node dissection among prostate cancer patients who underwent preoperative prostate-specific membrane antigen positron emission tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool. Eur Urol Oncol. 2023;6(6):543\u201352.","DOI":"10.1016\/j.euo.2023.05.003"},{"key":"130451","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.euo.2023.05.003","DOI":"10.1016\/j.euo.2023.05.003"},{"key":"130452","doi-asserted-by":"crossref","unstructured":"Van Bergen TD, Braat AJAT, Hermsen R, Heetman JG, Wever L, Lavalaye J, et al. External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancer. Eur J Nucl Med Mol Imaging. 2025;52(10):3744\u201356.","DOI":"10.1007\/s00259-025-07241-y"},{"key":"130453","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00259-025-07241-y","DOI":"10.1007\/s00259-025-07241-y"},{"key":"130454","doi-asserted-by":"crossref","unstructured":"Muehlematter UJ, Schweiger L, Ferraro DA, Hermanns T, Maurer T, Heck MM, et al. Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer. Eur J Nucl Med Mol Imaging. 2023;50(10):3137\u201346.","DOI":"10.1007\/s00259-023-06278-1"},{"key":"130455","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00259-023-06278-1","DOI":"10.1007\/s00259-023-06278-1"},{"key":"130456","doi-asserted-by":"crossref","unstructured":"Karakiewicz PI, Incesu RB, Scheipner L, Graefen M. Navigating nomograms to identify prostate cancer patients for lymph node dissection. Eur Urol Oncol. 2023;6(6):564\u20135.","DOI":"10.1016\/j.euo.2023.07.001"},{"key":"130457","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.euo.2023.07.001","DOI":"10.1016\/j.euo.2023.07.001"},{"key":"130458","doi-asserted-by":"crossref","unstructured":"Roberts MJ, Gandaglia G, Oprea-Lager DE, Stranne J, Cornford P, Tilki D. Pelvic lymph node dissection in prostate cancer: evidence and implications. Eur Urol. 2025;87(6):619\u201321.","DOI":"10.1016\/j.eururo.2025.03.004"},{"key":"130459","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.eururo.2025.03.004","DOI":"10.1016\/j.eururo.2025.03.004"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/43970\/51792","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/43970\/51792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:34:56Z","timestamp":1761132896000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/43970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":68,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2025.43970","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}